H.Res.93 — Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
House Roll Call
H.Res.93
| Bill | H.Res.93 — Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes. |
|---|---|
| Vote question | On Ordering the Previous Question |
| Vote type | Yea-and-Nay |
| Result | Passed |
| Totals | Yea 212 / Nay 208 / Present 0 / Not Voting 13 |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| R | 212 | 0 | 0 | 6 |
| D | 0 | 208 | 0 | 7 |
| I | 0 | 0 | 0 | 0 |
Research Brief
On Ordering the Previous Question
Bill Analysis
Bill Summary: HRES 93 (119th Congress)
HRES 93 is a resolution that provides for the consideration of H.R. 27, which aims to amend the Controlled Substances Act (CSA) concerning the scheduling of fentanyl-related substances. The resolution facilitates the legislative process by establishing the parameters under which H.R. 27 will be debated and voted upon in the House of Representatives.
Key Provisions: H.R. 27 proposes to permanently classify fentanyl-related substances as Schedule I drugs under the CSA. This classification indicates that these substances have a high potential for abuse, no accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. The bill seeks to address the escalating opioid crisis by ensuring that fentanyl analogs, which are often more potent and dangerous than traditional opioids, are regulated more stringently.
Funding/Authorities: The resolution itself does not allocate funding but sets the procedural framework for the House to consider the amendments to the CSA. If passed, H.R. 27 could lead to increased funding for law enforcement and public health initiatives aimed at combating the opioid epidemic, as it would empower federal and state agencies to take more decisive action against the trafficking and abuse of fentanyl-related substances.
Affected Programs/Agencies: The primary agencies impacted by this legislation include the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS), which oversee drug scheduling and public health responses to substance abuse.
Beneficiaries and Regulations: The bill is designed to benefit public health by potentially reducing the availability of dangerous fentanyl analogs, thereby protecting communities from overdose deaths and substance abuse. It regulates manufacturers, distributors, and users of these substances, imposing stricter penalties for violations.
Key Timelines: The latest action on HRES 93 was the motion to reconsider, which was laid on the table and agreed to without objection, indicating a procedural step that allows the House to move forward with consideration of H.R. 27. Further legislative actions will follow as the bill progresses through the House.
Yea (212)
K
Ken Calvert
S
Scott Franklin
M
Mark Green
L
Lisa McClain
J
John Rutherford
D
David Schweikert
P
Pete Sessions
Nay (208)
G
Gerald Connolly
J
Jason Crow
L
Lloyd Doggett
J
John Garamendi
J
John Mannion
L
Lucy McBath
E
Eric Swalwell
R
Rashida Tlaib
S
Sylvester Turner
N
Nydia Velázquez
D
Debbie Wasserman Schultz
